These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19498082)

  • 1. Achieving accurate compound concentration in cell-based screening: validation of acoustic droplet ejection technology.
    Grant RJ; Roberts K; Pointon C; Hodgson C; Womersley L; Jones DC; Tang E
    J Biomol Screen; 2009 Jun; 14(5):452-9. PubMed ID: 19498082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Streamlined system for purifying and quantifying a diverse library of compounds and the effect of compound concentration measurements on the accurate interpretation of biological assay results.
    Popa-Burke IG; Issakova O; Arroway JD; Bernasconi P; Chen M; Coudurier L; Galasinski S; Jadhav AP; Janzen WP; Lagasca D; Liu D; Lewis RS; Mohney RP; Sepetov N; Sparkman DA; Hodge CN
    Anal Chem; 2004 Dec; 76(24):7278-87. PubMed ID: 15595870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extraction, identification, and functional characterization of a bioactive substance from automated compound-handling plastic tips.
    Watson J; Greenough EB; Leet JE; Ford MJ; Drexler DM; Belcastro JV; Herbst JJ; Chatterjee M; Banks M
    J Biomol Screen; 2009 Jun; 14(5):566-72. PubMed ID: 19470712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of low-volume 1536-well assay-ready compound plates.
    Eriksson H; Brengdahl J; Sandström P; Rohman M; Becker B
    J Biomol Screen; 2009 Jun; 14(5):468-75. PubMed ID: 19470713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying actives from HTS data sets: practical approaches for the selection of an appropriate HTS data-processing method and quality control review.
    Shun TY; Lazo JS; Sharlow ER; Johnston PA
    J Biomol Screen; 2011 Jan; 16(1):1-14. PubMed ID: 21160066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological assay challenges from compound solubility: strategies for bioassay optimization.
    Di L; Kerns EH
    Drug Discov Today; 2006 May; 11(9-10):446-51. PubMed ID: 16635808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Best practices in compound management for preserving compound integrity and accurately providing samples for assays.
    Matson SL; Chatterjee M; Stock DA; Leet JE; Dumas EA; Ferrante CD; Monahan WE; Cook LS; Watson J; Cloutier NJ; Ferrante MA; Houston JG; Banks MN
    J Biomol Screen; 2009 Jun; 14(5):476-84. PubMed ID: 19483144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of the charged aerosol detector in compound management.
    Sinclair I; Charles I
    J Biomol Screen; 2009 Jun; 14(5):531-7. PubMed ID: 19483147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability through the ages: the GSK experience.
    Blaxill Z; Holland-Crimmin S; Lifely R
    J Biomol Screen; 2009 Jun; 14(5):547-56. PubMed ID: 19470717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming problems of compound storage in DMSO: solvent and process alternatives.
    Waybright TJ; Britt JR; McCloud TG
    J Biomol Screen; 2009 Jul; 14(6):708-15. PubMed ID: 19531665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality control procedures for dose-response curve generation using nanoliter dispense technologies.
    Quintero C; Rosenstein C; Hughes B; Middleton R; Kariv I
    J Biomol Screen; 2007 Sep; 12(6):891-9. PubMed ID: 17517899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing quality assurance criteria for serial dilution operations on liquid-handling equipment.
    Popa-Burke I; Lupotsky B; Boyer J; Gannon W; Hughes R; Kadwill P; Lyerly D; Nichols J; Nixon E; Rimmer D; Saiz-Nicolas I; Sanfiz-Pinto B; Holland S
    J Biomol Screen; 2009 Sep; 14(8):1017-30. PubMed ID: 19675311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of freeze/thaw cycles on the stability of compounds in DMSO.
    Kozikowski BA; Burt TM; Tirey DA; Williams LE; Kuzmak BR; Stanton DT; Morand KL; Nelson SL
    J Biomol Screen; 2003 Apr; 8(2):210-5. PubMed ID: 12844443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and implementation of an automated compound management system in support of lead optimization.
    Quintero C; Kariv I
    J Biomol Screen; 2009 Jun; 14(5):499-508. PubMed ID: 19487770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound precipitation in high-concentration DMSO solutions.
    Popa-Burke I; Russell J
    J Biomol Screen; 2014 Oct; 19(9):1302-8. PubMed ID: 24980595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of new technologies for cellular screening along the drug value chain.
    Möller C; Slack M
    Drug Discov Today; 2010 May; 15(9-10):384-90. PubMed ID: 20206290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-quality cost-effective compound management support for HTS.
    Zaragoza-Sundqvist M; Eriksson H; Rohman M; Greasley PJ
    J Biomol Screen; 2009 Jun; 14(5):509-14. PubMed ID: 19487769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of adaptive focused acoustics to compound management.
    Nixon E; Holland-Crimmin S; Lupotsky B; Chan J; Curtis J; Dobbs K; Blaxill Z
    J Biomol Screen; 2009 Jun; 14(5):460-7. PubMed ID: 19487768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems.
    Crivori P; Morelli A; Pezzetta D; Rocchetti M; Poggesi I
    Eur J Pharm Sci; 2007 Nov; 32(3):169-81. PubMed ID: 17714921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COMDECOM: predicting the lifetime of screening compounds in DMSO solution.
    Zitha-Bovens E; Maas P; Wife D; Tijhuis J; Hu QN; Kleinöder T; Gasteiger J
    J Biomol Screen; 2009 Jun; 14(5):557-65. PubMed ID: 19483143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.